Literature DB >> 22215738

Role of Francisella lipid A phosphate modification in virulence and long-term protective immune responses.

Duangjit Kanistanon1, Daniel A Powell, Adeline M Hajjar, Mark R Pelletier, Ilana E Cohen, Sing Sing Way, Shawn J Skerrett, Xiaoyuan Wang, Christian R H Raetz, Robert K Ernst.   

Abstract

Lipopolysaccharide (LPS) structural modifications have been shown to specifically affect the pathogenesis of many gram-negative pathogens. In Francisella, modification of the lipid A component of LPS resulted in a molecule with no to low endotoxic activity. The role of the terminal lipid A phosphates in host recognition and pathogenesis was determined using a Francisella novicida mutant that lacked the 4' phosphatase enzyme (LpxF). The lipid A of this strain retained the phosphate moiety at the 4' position and the N-linked fatty acid at the 3' position on the diglucosamine backbone. Studies were undertaken to determine the pathogenesis of this mutant strain via the pulmonary and subcutaneous routes of infection. Mice infected with the lpxF-null F. novicida mutant by either route survived primary infection and subsequently developed protective immunity against a lethal wild-type (WT) F. novicida challenge. To determine the mechanism(s) by which the host controlled primary infection by the lpxF-null mutant, the role of innate immune components, including Toll-like receptor 2 (TLR2), TLR4, caspase-1, MyD88, alpha interferon (IFN-α), and gamma interferon(IFN-γ), was examined using knockout mice. Interestingly, only the IFN-γ knockout mice succumbed to a primary lpxF-null F. novicida mutant infection, highlighting the importance of IFN-γ production. To determine the role of components of the host adaptive immune system that elicit the long-term protective immune response, T- and B-cell deficient RAG1(-/-) mice were examined. All mice survived primary infection; however, RAG1(-/-) mice did not survive WT challenge, highlighting a role for T and B cells in the protective immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215738      PMCID: PMC3294632          DOI: 10.1128/IAI.06109-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster.

Authors:  Monika K Ahlund; Patrik Rydén; Anders Sjöstedt; Svenja Stöven
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

4.  Human Toll-like receptor 4 recognizes host-specific LPS modifications.

Authors:  Adeline M Hajjar; Robert K Ernst; Jeff H Tsai; Christopher B Wilson; Samuel I Miller
Journal:  Nat Immunol       Date:  2002-03-25       Impact factor: 25.606

5.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.

Authors:  R K Ernst; E C Yi; L Guo; K B Lim; J L Burns; M Hackett; S I Miller
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

6.  Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.

Authors:  L S Anthony; P J Morrissey; F E Nano
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

Review 7.  Endotoxins: relationships between structure, function, and activity.

Authors:  Klaus Brandenburg; Andre Wiese
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

8.  MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival.

Authors:  Crystal M Lauriano; Jeffrey R Barker; Sang-Sun Yoon; Francis E Nano; Bernard P Arulanandam; Daniel J Hassett; Karl E Klose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

9.  Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia.

Authors:  M J Greenberger; R M Strieter; S L Kunkel; J M Danforth; L L Laichalk; D C McGillicuddy; T J Standiford
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

10.  A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

Authors:  J E Somerville; L Cassiano; B Bainbridge; M D Cunningham; R P Darveau
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more
  17 in total

Review 1.  Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.

Authors:  Nicole P Giordano; Melina B Cian; Zachary D Dalebroux
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  Microbial Lipid A Remodeling Controls Cross-Presentation Efficiency and CD8 T Cell Priming by Modulating Dendritic Cell Function.

Authors:  George Papadopoulos; Robert Berland; Ashwini Sunkavalli; Stephen R Coats; Richard P Darveau; Caroline A Genco
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

3.  Characterization of tetratricopeptide repeat-like proteins in Francisella tularensis and identification of a novel locus required for virulence.

Authors:  Vera Dankova; Lucie Balonova; Adela Straskova; Petra Spidlova; Daniela Putzova; Todd Kijek; Joel Bozue; Christopher Cote; Sherry Mou; Patricia Worsham; Barbora Szotakova; Lukas Cerveny; Jiri Stulik
Journal:  Infect Immun       Date:  2014-09-22       Impact factor: 3.441

4.  Metabolic labeling to characterize the overall composition of Francisella lipid A and LPS grown in broth and in human phagocytes.

Authors:  Jason H Barker; Justin W Kaufman; De-Sheng Zhang; Jerrold P Weiss
Journal:  Innate Immun       Date:  2013-05-31       Impact factor: 2.680

5.  Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock.

Authors:  Jon A Hagar; Daniel A Powell; Youssef Aachoui; Robert K Ernst; Edward A Miao
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

6.  Lipid A Structural Divergence in Rickettsia Pathogens.

Authors:  Mark L Guillotte; Courtney E Chandler; Victoria I Verhoeve; Joseph J Gillespie; Timothy P Driscoll; M Sayeedur Rahman; Robert K Ernst; Abdu F Azad
Journal:  mSphere       Date:  2021-05-05       Impact factor: 4.389

Review 7.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013

Review 8.  Uncovering the components of the Francisella tularensis virulence stealth strategy.

Authors:  Bradley D Jones; Matthew Faron; Jed A Rasmussen; Joshua R Fletcher
Journal:  Front Cell Infect Microbiol       Date:  2014-03-07       Impact factor: 5.293

9.  Type VI Secretion System and Its Effectors PdpC, PdpD, and OpiA Contribute to Francisella Virulence in Galleria mellonella Larvae.

Authors:  Maj Brodmann; Sophie T Schnider; Marek Basler
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

Review 10.  Kdo2 -lipid A: structural diversity and impact on immunopharmacology.

Authors:  Xiaoyuan Wang; Peter J Quinn; Aixin Yan
Journal:  Biol Rev Camb Philos Soc       Date:  2014-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.